Similarly, some researchers analyzed the transcriptome profiles and related clinical information of 1090 breast cancer patients recorded in the Cancer Genome Atlas database and found that the expression of CD80 was closely related to the malignant degree of breast cancer, which also indicated that CD80 may be a promising target for immunotherapy strategy (35). The gene discussed is CD80; the disease is breast carcinoma.